US Equity Research

Progressive Waste Solutions Equity Analysis

2012-01-06T18:16:00.002-05:00

2011-12-04T22:28:00.000-05:00

My next post will be on Jan 9, 2012.

-- Ketul

Stock of the month

2011-12-04T22:24:00.002-05:00

This month my stock recommendation is International Flavors and Fragrances (NYSE: IFF). I've recommended this stock in July of this year and you can check out the slides from July in this blog's history. It's @ 16% cheaper now and so I like it even more. The rest of the story remains intact and the price decline is just due to the market volatility.

Varian Medical Equity Analysis

2011-09-11T22:55:00.001-04:00

2011-07-11T10:44:00.001-04:00

My next post will be on Aug 8.
--Ketul

International Flavors & Fragrances

2011-07-11T10:41:00.001-04:00

Equifax Analysis

2011-06-06T10:59:00.004-04:00

Let's say you owned a business where your customers store their valuables with you and every time they want to access it they pay a fee to you. Plus, they also buy insurance from you for the safety of those very valuables, just in case they were stolen. Isn't that a wonderful business ? Cherry on the cake, customers have to buy this service at birth and continue paying for it by law till death. If they don't like your price they only have two other options which are equally expensive. So, if you like this business, you'll like equifax, it's one of the 3 credit data providers. Equifax is one of the three companies that maintains your credit history and provides a credit score. It's quite cheap on a pe and cash flow basis and it falls in the category of businesses where the management can play golf the whole day and earnings won't change a tiny bit. I have posted slides on this stock in 2009, the story hasn't changed, the drivers are the same and it's still selling at fair to undervalued levels. Here's a link to my slides from 2009: http://usequity.blogspot.com/2009/08/equifax-equity-analysis.html

-- Ketul

Nalco Holding Company Equity Analysis

2011-05-02T23:13:00.003-04:00

Nielsen Holdings Equity Analysis

2011-04-03T21:59:00.003-04:00

New York Community Bancorp

2011-03-06T20:15:00.005-05:00

Psychemedics Corporation Equity Analysis

2011-02-06T22:47:00.005-05:00

Tupperware Brands Equity Analysis

2011-01-09T21:13:00.005-05:00

December Post

2010-12-06T13:54:00.002-05:00

I'm on a vacation in december and will skip my december post. The next stock post will be on Jan 8/9 of 2011.

--Ketul

Teva Pharmaceutical

2010-11-07T22:40:00.004-05:00

International Speedway Corp. Equity Analysis

2010-10-03T23:07:00.004-04:00

2010-09-30T23:04:00.001-04:00

My next post with October's stock presentation will be on 3-4 October.

--Ketul

FISERV Equity Analysis

2010-09-13T07:25:00.003-04:00

2010-08-02T22:08:00.001-04:00

My next stock post will be on September 12/13, 2010.

--Ketul

Teva Pharmaceuticals

2010-08-01T23:20:00.007-04:00

Walmart

2010-07-12T09:00:00.000-04:00

The stock for this month is Walmart - WMT, at Friday's closing price of $49.42 is a good buy. It has low downside potential and reasonably good upside in many different macroeconomic scenarios. The discounted cash flow valuation is a lot higher between $75-80 but for the market to give such a multiple to WMT, it'll need to assure the street of a long term sustainable growth from international markets pushing up the overall eps growth to the 12-15% range. However, WMT can easily hit $57-60 range even with lower growth while the downside from $49.42 is quite low.

Please check my earlier post from Oct 2009 for slides on WMT.

Stock of the month

2010-06-15T09:30:00.002-04:00

With the volatile markets in May, I didn't get a chance to research for a new stock for June but some of the stocks I discussed in the past are selling at reasonable to discounted price levels. So, for this month my recommendations:-

* Mastercard - (MA) at $184. It's trading about 10% higher right now but with the current volatility you never know.

* Nasdaq - (NDAQ) at $18.50. Good value at that price.

* Equifax - (EFX) at $26.5.

My next post will be on July 11 since the first sunday of next month is a long weekend.

-- Ketul

Baxter International Stock Analysis

2010-04-30T17:40:00.005-04:00

MLPI - UBS ETN for Alerian MLP infrastructure inded

2010-04-12T09:55:00.002-04:00

TBT - Proshares Ultrashort 20+ year treasury

2010-04-12T09:54:00.002-04:00

April Stock posting delayed

2010-04-05T09:39:00.000-04:00

Due to the long weekend we just had, I'll post the April stock of the month on the second Monday of the month (04/12).

-- Ketul

Dish Network Equity Analysis

2010-03-07T22:31:00.003-05:00

March Posting Delayed

2010-02-28T14:29:00.001-05:00

I'll post the March stock of the month on the second Monday of the month (03/08).

-- Ketul

Carriage Services Equity Analysis

2010-02-08T23:19:00.007-05:00

Posting Delayed

2010-02-01T14:12:00.001-05:00

Unable to post a new stock this Monday due to extraordinary work load but will post a new stock on Feb 7 (Second Monday of the month).......Ketul

Nasdaq Equity Analysis

2010-01-11T12:39:00.003-05:00

Brinks Company Equity Analysis

2010-01-04T08:25:00.000-05:00

December Post Delayed

2009-12-14T13:19:00.001-05:00

I'm on a vacation in December and hence the december stock pick of the month was not posted. My next post will be on the first Monday of Jan with the Jan stock pick of the month.

-- Ketul

Investment Style and Disclosure

2009-11-01T22:32:00.002-05:00

Disclaimer: I will post a new stock pick on the first Monday of every Month. I (and the companies I'm associated with) may have Long/Short positions in the stocks recommended on this blog. Please contact your investment advisor for buying/selling securities as these stocks may not be suitable for you.

Investment Style & Performance:

Here's a link to the historical performance of my stock fund at a third party site, Marketocracy.com: Performance.

Very often we hear that to beat the market one needs to be right only 51% of the time, however, most people focus only on finding the next excellent stock and hence work on the 51% part of equation while neglecting the 49% which is the part when a wrong stock was selected. Logically, one should spend 49% of his/her research in avoiding mistakes. So far the best way I've found to avoid mistakes is by reading other people's mistakes. I try to read each and every book on investments from famous portfolio managers, traders and professors going back to the beginning of the 20th century. Moreover, I also read as much as possible about different industries to get a better understanding before investing in them. Obviously, this still doesn't guarantee that I won't do mistakes of my own but it does help in avoiding mistakes that someone has already well documented.

My investment approach is a combination of top-down and bottom-up security selection process. I select sectors and geographies for a equity portfolio by conducting macroeconomic analysis of regions and sectors while maintaining portfolio risk within acceptable limits for investors. Macro analysis plays a prominent role in reducing the total risk (volatility) of the portfolio and maximizing expected returns for a particular level of risk. I also use a few derivative strategies to maximize portfolio returns without adding undue risk to the portfolio.

Once a sector or industry is selected for investment based on macro analysis and portfolio risk requirements, I use a bottom-up security selection process to find companies with sustainable competitive advantages with-in an industry. A quant screen comprising factors such as net profit margin, gross margin, financial leverage, asset turnover, EPS growth, revenue growth, PEG and PE ratio narrows down the list of companies to less than 10 in most instances. At this point, I apply industry specific parameters; every industry has specific measures that can be used to understand the competitive advantages of various companies. This will further narrow down the list to 3-4 companies.

Valuation: Furthermore, a detailed financial statement analysis helps me understand these 3-4 companies and how they are priced relative to peers; finally our time-tested equity valuation model, Scenario analysis, Sensitivity analysis, Comparable analysis and other such methods provide the target price of an equity. These companies are also analyzed for portfolio suitability based on expected returns, systematic risk and total risk of the portfolio.

However, every instance of the above analysis _does_not_ result in a recommendation. Sometimes the equity selected is overpriced and is placed on a watch-list. I follow companies for many years and repeat the above analysis when they get close to my preferred buying price. Most of the companies I recommend have been on my watch for atleast six months. Finally, the portfolio is analyzed regularly to sell equities that have reached their target price and provide a low return for the risk exposure.

Portfolio Risk Analysis: We use Modern Portfolio Theory to balance portfolios; we prefer adding equities that are either uncorrelated or negatively correlated to maximize returns per unit of risk. This does_not mean that we would select stocks just because of their correlation to a portfolio; once a stock is selected for investment based on thorough bottom-up research, correlation is used to optimize the risk-return graph for different allocations within the selected list of stocks.

For Questions/Comments: e-mail ketuls@gmail.com

Corinthian Colleges Stock Analysis

2009-11-01T22:27:00.004-05:00

Walmart Equity Analysis

2009-10-05T09:33:00.006-04:00

Becton Dickinson & Co Stock Analysis

2009-09-13T20:25:00.004-04:00

Equifax Equity Analysis

2009-08-03T18:29:00.000-04:00

Hansen Natural Stock Recommendation

2009-07-12T21:01:00.005-04:00

Delay in posting stock of the month

2009-06-01T10:35:00.001-04:00

Due to the extra work load this week, I'll post this month's stock pick on the second monday of the month.

Life Partners Holdings Equity Analysis

2009-05-03T15:05:00.007-04:00

Psychiatric Solutions Equity Analysis

2009-04-05T18:07:00.008-04:00

Philip Morris International Stock Analysis

2009-03-09T08:42:00.002-04:00

Sector – Consumer Staples

Investment Style – Large Cap

Current Price-$33.34

Price Target - $66

Trade Tip: Short PM’s 3.9% yield 2013 bond and go long on PM stock with a dividend yield of 6.5%. Arbitrage value, assuming non-material trading cost and no change in PM’s dividend, is 2.6 percentage points. I’m not considering the risk of decline in stock price because by buying the stock an investor is assuming that risk already and this is just an option to the simple long on stock strategy. The probability of a dividend cut or a further decline in PM’s bond yield is pretty low.

Valuation: A DCF valuation of PM yields a price of $66, an upside potential of 100% to Friday’s (03/06) closing price of $33.34. The valuation model is sensitive to changes in short-term revenue growth (5%), sustainable net profit margin (11.5%) and long term cost of equity (9.7%). PM’s 2008 revenue growth has been in the 6% range and net profit margin in the 11% range. PM’s revenues are well diversified geographically and it operates in a stable tobacco industry; a cost of equity of 9.7% is quite conservative for such stable firms.

PM doesn’t have a long enough trading history but its former parent MO has been trading in the PE range of 11X to 18X in the last five years; PM with its estimated EPS of $3 for 2009 could trade in the $33 to $54 range in 2008-2009. At its current quote, the stock is trading at the low end of the historical PE valuation. Moreover, it’s PEG ratio is 0.9 with a PE of 10 and an estimated 11% EPS growth in 2009. Additionally, a 6.5% dividend yield reduces the downside risk of this stock. PM’s P/S ratio is 2.77 while its P/Free CF is at 9.7.

PM’s earnings yield (NI/Market Cap) for 2008 is at 10.3% while it bond yield is at 3.4%. This spread of 7.9% between PM’s earnings yield and bond yield combined with a 6.5% dividend yield more than justifies buying PM stock when compared to its bond. It’s TEV/EBIT for 2008 is at 7.5 while free cash flow (CFO-CFI) was at 10% of its current market cap.

Profitability Analysis: PM’s ROE has increased to 60% in 2008 from 39% in 2007 owing to a slight increase in asset turnover and almost doubling of financial leverage.

Growth Catalysts: PM achieved impressive international growth as a part of Altria and was spun-off in April 2008 with rights to market PM brands in all countries but the US. PM can achieve much better results with its focus on international markets without the baggage of US litigation risk and regulation.

In Dec 2007, PM formed a joint venture with China National Tobacco to manufacture PM branded cigarettes in China; the production is on schedule and it has started contributing in Q4-2008 (although not material so far) to the top-line. PM’s Asian revenues (excluding China) grew at a CAGR of 6.2% in 2008 and the introduction of PM brands in China could push this growth rate into double digits in 2009-2010. Similarly, India is another growing market for cigarettes and PM is in talks to manufacture Marlboro locally. Chinese and Indian growth has not been factored in the valuation model so far since it is not expected to be materially significant in the next few quarters. In 2008, EMEA has been the fastest growing region (in terms of revenues) at a CAGR of 13.6% while sales in Europe declined in 2008 by 0.8%. Moreover, PM’s three year $1.5 billion productivity and cost savings program is on track with the first big element of resourcing of volume from US factories to PMI factories expected to be about two months ahead of schedule. EPS is expected to grow by 11% in 2009 and 12% in 2010.

Insider Trading: All insiders including the CFO have bought shares in the $50 range without a single insider sell transaction below $42 in the last one year. In May 2008, PM announced a $13 billion two-year share repurchase program; in 2008, PM spent $5.4 billion of the $13 billion on buy backs. The remaining $7.6 billion constitutes 11.3% of its market cap based on PM’s March 06 closing price.

Tobacco Sector Analysis: Extensive regulation, taxes and litigations risks have hampered the growth of this industry in much of the developed world. Litigation risk is high in US but almost non-existent in emerging markets. PM is not liable for any litigation in the US since Altria owns all of PM’s brands in US. All these issues have also led to consolidation in the industry in the last few years and increased barriers to entry. Tobacco industry has a HHI of 3100 and the top ten brands from the big four tobacco companies make up about 80% of the market; PM owns seven out of the top 15 brands in the world. The high cost of litigation, lobbying various governments and creating a brand benefits companies with scale in this industry. It is almost impossible to quickly penetrate this market with a new brand and so competition in this industry is more likely to come from existing players acquiring local brands.

Tobacco producers are scattered around the world and hence don’t have a lot of bargaining power while negotiating prices for their produce. On the other hand, consumers can switch to cheaper brands if the economic conditions warrant such a change and so brand recognition is the key to retaining consumers. A variety of products compete for the consumer’s tobacco dollars, however, once a consumer is addicted to a particular type of tobacco, it is difficult for other products to gain prominence.

Risk Factors: PM’s European volume shipments have been on a decline in the past one year and Europe is the largest revenue generator for PM with a revenue share of 36% in 2008. PM’s growth in emerging markets has to offset the decline in EU shipments. A world-wide recession could hurt PM’s sales since it sells premium brands and most of its new customers trade-up from local cigarette brands. However, the current revenue and EPS estimates have considered these declines to quite an extent.

Litigation costs and increasing regulation in developed countries is a major concern for tobacco companies. PM doesn’t generate revenues from US and is unlikely to be liable for any litigation in US; it is also immune to any future US regulation. Anti-tobacco laws in other regions of the world are not strict enough to cause any material impact on PM’s bottom-line. The recent acquisition of Rothmans in Canada is the only major source of litigation risk for PM.

All of PM’s revenues are from international operations and so it has significant currency risk. However, it could be a natural hedge against the dollar for investors with extensive US investments.

Conclusion: PM has limited downside risk in the current oversold market conditions with above average dividend yield and high growth potential owing to its strong brands and low penetration in major emerging market countries such as China, India and Vietnam.

Disclosure: The author and his firm are long on PM

Corrections Corporation of America Equity Analysis

2009-02-01T16:33:00.013-05:00

MasterCard Equity Analysis

2009-01-05T07:25:00.003-05:00

American Tower: A nonregulated utility with high growth prospects

2008-11-23T19:02:00.009-05:00

Hansen Natural Equity Analysis

2008-11-03T06:42:00.019-05:00

Hansen Natural Business Analysis

Branding and Distribution are key competitive advantages; difficult for new entrants to gain market share

Hansen has created a strong brand (Monster)
Distribution contracts with major Coke and Bud distributors in US as well as six European countries

Consumers are price inelastic between different brands

Firms don’t compete on price

Consumers are addicted to a certain extent to particular energy drinks since they provide a quick boost in energy levels

Psychological barriers to switching brands
Coffee gives bad breadth and brown teeth; energy drinks avoid such problems and have no taste memory

Business model has high operational leverage

Incumbents can leverage economies of scale

Phillip Morris International: A costless call option on growth in emerging markets

2008-09-22T21:00:00.010-04:00

Valuation: JFCG's valuation of PM yields a price of $74, an upside potential of 48% to today’s (09/22) closing price of $50. The valuation model is sensitive to changes in short-term revenue growth (10.1%), sustainable net profit margin (11.4%) and sustainable cost of equity (9.3%). PM’s y-o-y revenue growth for the last two quarters has been in the 14% range and net profit margin has been in the 11-12% range. PM’s revenues are well diversified geographically and it operates in a stable tobacco industry; a cost of equity of 9.3% is quite conservative for such stable firms. PM doesn’t have a long enough trading history but its former parent MO has been trading in the PE range of 13X to 18X in the last five years; PM with its average estimated EPS of $3.75 for 2009 could trade in the $49 to $68 range in 2008-2009.

Scenario & Sensitivity Analysis: A scenario analysis shows that PM’s current stock price reflects low short term revenue growth at 2% or a low sustainable net profit margin of 7%; either one of which has a low probability. PM’s intrinsic value is more sensitive to net profit margins; each percentage point in net margins is equivalent to $5.5/share of intrinsic value. Net profit margins at PM have been very stable and is unlikely to change anytime soon.

Tobacco producers are scattered around the world and hence don’t have a lot of bargaining power while negotiating prices for their produce. On the other hand, consumers can easily switch to cheaper brands if the economic conditions warrant such a change and so brand recognition is the key to retaining consumers. A variety of products compete for the consumer’s tobacco dollars, however, once a consumer is addicted to cigarettes, it is difficult for other products to gain prominence.

In Dec 2007, PM formed a joint venture with China National Tobacco to manufacture PM branded cigarettes in China and are expected to hit the markets in Q3-2008. PM’s Asian revenues (excluding China) grew at a CAGR of 9% in the past three years and the introduction of PM brands in China could push this growth rate into double digits in 2009-2010. Similarly, India is another growing market for cigarettes and PM is in talks to manufacture Marlboro locally. Chinese and Indian growth has not been factored in the valuation model so far since it is not expected to be materially significant in the next few quarters. In the last three years, EMEA has been the fastest growing region with a CAGR of 11%.

All insiders including the CFO have bought shares in the $50 range without a single insider sell transaction below $52 in the last six months. In May 2008, PM announced a $13 billion two-year share repurchase program; as of Q2-2008, it has spent $2.1 billion out of the $13 billion approved by the Board of Directors. PM’s three year $1.5 billion productivity and cost savings program is on track with the first big element of resourcing of volume from USA factories to PMI factories expected to be about two months ahead of schedule.

Risk Factors: PM’s European volume shipments have been on a decline in the past one year and Europe is the largest revenue generator for PM with a revenue share of 49% in 2007. In the past three years, PM was able to offset lower volume shipments in EU by increasing prices and the overall revenues grew at a CAGR of 3.8%. Overall, PM’s growth in emerging markets has to make up for the decline in EU shipments.

An increase in inflation world-wide could hurt PM’s sales since it sells premium brands and most of its new customers trade-up from local cigarette brands. However, in case of PM, inflation is a double edged sword: it could mean weak sales for PM in certain regions but the underlying reason for world-wide inflation is that more consumers have resources to buy goods, which increases the international customer base for PM products.

Overall, PM has limited downside risk in current volatile market conditions with above average growth potential owing to its strong brands and low penetration in major emerging market countries such as China, India and Vietnam.

IMS Health

2008-09-08T08:11:00.012-04:00

Nike Equity Analysis

2008-07-28T09:51:00.022-04:00

Portfolio Suitability: In the last three years, Nike’s correlation to consumer discretionary sector is at 0.01. In simple terms, for the last three years, Nike’s stock doesn’t have any relation to the movement of consumer discretionary sector. So, even though Nike is considered to be a consumer discretionary stock, its stock isn’t behaving in line with the sector. The reason for this anomaly could lie in the fact that most consumer discretionary stocks are heavily dependent on US for their revenues while Nike isn’t. Infact, Nike’s three year correlation to the consumer staple sector is at 0.91 and at 0.89 to the utilities sector. This reinforces the theory that Nike will not be severely affected by a further slide in the US economy.

Sector Performance: Nike belongs to the consumer discretionary sector, a sector which we have been underweight since we started seeing some signs of an economic downturn in the US in June (2007) when an inverted yield curve puzzled everyone. An inverted yield curve is almost always a leading indicator of an economic slowdown since forward yields are low in one of the two circumstances; either the GDP growth is expected to decline or inflation is expected to decrease. However, with central banks worldwide having trouble keeping inflation at bay, the possibility of decline in GDP growth was more realistic. A decline in GDP wouldn’t bode well for the consumer discretionary sector and so we have been underweight on that sector for quite some time now. In the first half of 2008, we have seen a slowdown in GDP growth coupled with high inflation. However, the yield curve is now upward sloping and so GDP growth is expected to pick-up sometime next year (2009). This begs the question if it is a good time to get back into the consumer discretionary sector while it is still reeling from an effect of a downturn and selling at a discount; XLY - Consumer Discretionary SPDR - is selling close to its five year lows in the mid 20s. The yield curve is just one indicator of GDP growth and so I looked at performance of XLY during the last economic recession; I used the last recession as a point of comparison since the macroeconomic conditions would be the closest, if not the same, for companies operating in the last 10 years. As we can see in the first chart, XLY underperformed S&P only for one year – 2000 - during the last recession. We want to check the performance of XLY in the last one year; the next chart compares XLY’s performance with S&P in the last one year and it has underperformed the S&P by about 10 percentage points. However, given the current credit market turmoil, I was still a little wary of this sector. Focusing on companies with extensive international exposure would mitigate the risk of a prolonged downturn in the US markets and Nike tops that list, moreover, Nike is underpriced which makes for a good value investment.

Nike’s Stock Performance: NKE’s stock closely followed XLY during the first recession of this decade and underperformed the S&P for about one year in 2000-2001. In the last one year, Nike has outperformed the S&P by about 15 percentage points while XLY has underperformed the S&P by 10 percentage points. Clearly, Nike is not following declines of the consumer discretionary sector in this downturn and that could be because of its extensive international exposure. In 1999-2000, Nike’s revenues from US were at 52% while 34% of Nike’s TTM revenues are from US. The recent slide in Nike’s price is attributed to flat orders from US for the rest of 2008 and so a slowdown in the US is already priced in the stock. The market ignored Nike’s excellent performance in the international segment. Nike’s revenues are well diversified and a slowdown in any one region of the world is less likely to have a significant impact on Nike’s overall performance.

Growth Catalysts: In the short term, revenue growth from Olympics will continue to provide support to the stock price. Nike is sponsoring 22 of China’s 28 Olympic teams. Moreover, Nike is expanding its distribution in China to 500 cities in the next three years from the current 300 cities. Basketball is the most popular sport in China and Nike is well established in that segment worldwide and has extensive experience in US basketball segment. Soccer is one of the most popular games in Nike’s growth regions – EMEA, Asia Pacific and Americas. Nike was historically a second rung player in the soccer segment but is now pursuing it aggressively; Nike bought Umbro in 2007 to strengthen its position in the soccer segment. Nike’s soccer teams did extremely well in the 2008 European Championships with five of the eight quarter finalists sponsored by Nike. Nike’s focus on Soccer will also boost sales in emerging markets such as Brazil and Russia.

Industry Analysis: The athletic footwear industry is in consolidation mode and Nike’s two top rivals, Adidas and Reebok merged in 2006. The global sports footwear market is almost an oligopoly between Nike and Adidas-Reebok. Oligopolistic competition could be good or bad for the participants based on whether the participants engage in a price war. Oligopolistic competition between Intel and AMD proved to be destructive for the industry due to a price war while the same between Pepsi and Coke without the price war is beneficial to both companies. Fortunately, Nike and Adidas-Reebok have avoided getting into a price war. This may also be due to the fact that consumers of Nike-Adidas sports gear are relatively inelastic to price since that expenditure forms a small part of their total expenditure. The demand curve in such a market is kinked and so is inelastic to price decreases; firms don’t gain a substantial number of customers by reducing prices. In such cases, firms utilize non-price competition in order to accrue higher revenue and market share. By definition, participants in an Oligopolistic market have significant economies of scale advantage and present strong entry barriers. Nike has distribution deals with large retailers which guarantees shelf space; it also has a size advantage when negotiating sourcing and sponsorship contracts.

Valuation: Our valuation model yields a price of $68/share while its current price is $57.24; undervalued by 19%. The valuation model uses a short term CAPM cost of equity of 8% and a long term CAPM cost of equity of 9%. Net profit margin is constant at 10% since Nike has an excellent track record of improving profitability and its TTM net profit margin is at 10.11%.

A scenario analysis of the above valuation model shows that its current stock price of $57.24 reflects a lower net profit margin of 8.5% or a slower short term revenue growth of 6.5%. The probability of an 8.5% net profit margin or a 6.5% revenue growth is extremely low and hence its current price has sufficient built-in margin of safety.

Nike maintains a lower effective tax bracket (24.7% for the last quarter) since it doesn’t repatriate earnings from international operations and instead uses it to grow in those regions. We view this arrangement to be very beneficial since Nike’s stock value is extremely sensitive to net profit margins; a one percentage point change in net profit margin is equivalent to $6/share while each percentage point in revenue growth is equivalent to $3/share in Nike’s intrinsic value. In the last five years, Nike has traded in the range of 14x to 25x earnings and at an estimated EPS of $3.95 for FY 2009, Nike’s stock should trade in the range of $55 to $98. Nike will also have support on the downside from a $2.2 billion share buyback approved for the next two years; in Fiscal 2008 (May 2007 to 2008), Nike spent $817 million on buybacks. Nike is relatively inexpensive at a PEG of 1.1 and has doubled its dividend in the last two years. Moreover, insiders haven’t sold a single share in the last one year below $57.08 with majority of the sell trades above $66 levels. Given the current uncertain market conditions, Nike is a perfect defensive (beta at 0.85), underpriced stock and has significant upside potential once the markets get out of the bear territory. Overall, it’s a consumer discretionary stock with the downside risk of a consumer staple and upside potential of a consumer discretionary stock.

Williams Companies Inc Stock Analysis

2008-07-14T08:00:00.032-04:00

Story Slide:

Natural gas contracts quoted on the NYMEX are for delivery at Henry Hub in Louisiana and a nexus of 16 intra- and interstate natural gas pipelines deliver NGL to the US East Coast, Gulf Coast and Midwest. NGL accounts for 30% of the energy consumption of US and is mostly used for producing electricity. The fastest growing supply of NGL in the US is from the Rocky Mountains and the three key basins in the Rockies, Green River, Piceance and Powder River are expected to grow production by 22%, 56% and 11% respectively between 2007 to 2011. However, upto May 2008, there wasn’t enough pipeline capacity to deliver gas from these regions to Henry Hub or to the major consumers in the US East Coast and Midwest regions. Hence, the Rockies gas traded at a discount of $5-$7 minus the NYMEX contract in 2007. In May 2008, Kinder Morgan completed a 713 mile NGL pipeline connecting the Rockies to Audrain County, Mo. where it interconnects with Kinder Morgan Interstate Gas Transmission system. This has reduced the Rockies gas discount to about $2 minus the NYMEX contract. Furthermore, this pipeline is expected to reach the East Coast by June 2009 which is when the discount to NYMEX NGL contract will be eliminated completely. Williams’ 81% of proven and 93% of possible NGL reserves are in the Rockies and could be a major reason why Williams has not hedged about 50% of its 2008-09 production.

Veolia Environment Stock Analysis

2008-06-30T07:44:00.011-04:00

ICICI Bank - NYSE - IBN Stock Analysis

2008-06-01T00:10:00.017-04:00

\
Story Slide:

The obvious question that investor's have regarding banking stocks is, what if the story of US banks' asset write downs and earnings losses is repeated in emerging markets such as India.
However, there are a few subtle differences between Indian banks and their US counterparts and that is what makes Indian banks less likely to follow the path of asset write downs.

First, Indian banks have very low exposure to structured finance investments in the US market. The next issue is about home loans and credit card loans that the Indian banks originate in the Indian market. At this point, it is important to understand the difference between a home loan originated by a US bank vs. a home loan originated by an Indian bank.

A home loan issued by a US bank is typically pooled as a MBS and sold to investors which leaves the risk of default with the MBS investors (typically a group of financial institutions) while the bank that originated the loan only services the loan and the loan doesn't show on the originating banks' balance sheet. The originating bank is not liable in case of a home loan default and hence has little to no incentive in checking the ability of the home loan borrower to repay the loan. To make matters worse, the originator bank is paid for originating the loan which means that the banks are incentivized to originate as many loans as possible without checking the credit quality of the borrower.

This is not true for banks in India since the home loans originated by banks are serviced and carried on their balance sheet as well as accounted for in NPA estimation. It is this very subtle difference that makes all the difference in the quality of home loans issued by Indian banks. In this case, the originator (Indian bank) is liable for default and hence has an incentive to check the ability of the borrower to repay the loan. Nationalized banks in India such as SBI, Central Bank of India etc. issue loans to poor credit customers owing to political pressure and also have to write off some debt every year to certain classes of customers as a part of government programs to help those classes, however, private sector banks such as IBN are under no such obligation and hence have better performing loan portfolios compared to their nationalized counterparts.

Philip Morris International Stock Pitch

2008-05-04T08:48:00.009-04:00

Western Union Stock Pitch

2008-04-07T12:35:00.003-04:00

Moody's Corporation Stock Pitch

2008-03-10T06:39:00.005-04:00

Infosys Technologies (ADR) Stock Pitch

2008-02-04T10:29:00.003-05:00

Spectra Energy Stock Pitch

2008-01-07T23:33:00.003-05:00

Zimmer Holdings Stock Pitch

2007-12-03T18:34:00.004-05:00

ArcelorMittal - NYSE - MT (ADR) Stock Pitch

2007-11-03T17:48:00.004-04:00

UnitedHealth Group Stock Pitch

2007-10-09T14:35:00.003-04:00

Coca Cola Co. Stock Pitch

2007-10-09T14:28:00.005-04:00

Please contact ketuls@gmail.com for a detailed stock report and valuation model for this presentation.

US Equity Research

Progressive Waste Solutions Equity Analysis

Next Post

Stock of the month

Varian Medical Equity Analysis

Next Post

International Flavors & Fragrances

Equifax Analysis

Nalco Holding Company Equity Analysis

Nielsen Holdings Equity Analysis

New York Community Bancorp

Psychemedics Corporation Equity Analysis

Tupperware Brands Equity Analysis

December Post

Teva Pharmaceutical

International Speedway Corp. Equity Analysis

Next post

FISERV Equity Analysis

Next Post

Teva Pharmaceuticals

Walmart

Stock of the month

Baxter International Stock Analysis

MLPI - UBS ETN for Alerian MLP infrastructure inded

TBT - Proshares Ultrashort 20+ year treasury

April Stock posting delayed

Dish Network Equity Analysis

March Posting Delayed

Carriage Services Equity Analysis

Posting Delayed

Nasdaq Equity Analysis

Brinks Company Equity Analysis

December Post Delayed

Investment Style and Disclosure

Corinthian Colleges Stock Analysis

Walmart Equity Analysis

Becton Dickinson & Co Stock Analysis

Equifax Equity Analysis

Hansen Natural Stock Recommendation

Delay in posting stock of the month

Life Partners Holdings Equity Analysis

Psychiatric Solutions Equity Analysis

Philip Morris International Stock Analysis

Corrections Corporation of America Equity Analysis

MasterCard Equity Analysis

American Tower: A nonregulated utility with high growth prospects

Hansen Natural Equity Analysis

Phillip Morris International: A costless call option on growth in emerging markets

IMS Health

Nike Equity Analysis

Williams Companies Inc Stock Analysis

Veolia Environment Stock Analysis

ICICI Bank - NYSE - IBN Stock Analysis

Philip Morris International Stock Pitch

Western Union Stock Pitch

Moody's Corporation Stock Pitch

Infosys Technologies (ADR) Stock Pitch

Spectra Energy Stock Pitch

Zimmer Holdings Stock Pitch

ArcelorMittal - NYSE - MT (ADR) Stock Pitch

UnitedHealth Group Stock Pitch

Coca Cola Co. Stock Pitch